Skip to content

EASYTRAK® 3 4525Recalls & reported problems

Boston Scientific Corporation · Coronary Venous Steroid-Eluting Bipolar Pace/Sense Lead · Class 3 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Quick summary

This Boston Scientific EASYTRAK 3 4525 is a steroid-eluting lead implanted alongside a cardiac resynchronization defibrillator (CRT-D). The 30 reports mostly describe leads that needed surgical removal because of infection, sepsis, or growths on the lead, plus leads that stopped pacing properly, moved out of position, or broke off and stayed inside a coronary vein. Reports describe 28 injuries and no deaths. No recalls name this lead.

AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.

Adverse event reports
30
Deaths reported
0
Injuries reported
28
Recalls naming it
0

Summary

The FDA's MAUDE database contains 30 adverse event reports that list this exact device (DI 00802526353772), received between Jul 16, 2016 and Aug 21, 2025 — classified as 28 injuries, 2 malfunctions.

The most frequently reported specific device problem is “High Capture Threshold” (8 reports).

19 other recalls cover devices cleared under the same FDA submission (P010012); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 1 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 1 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 1 reportsMay 2025: 2 reportsJun 2025: 1 reportsJul 2025: 0 reportsAug 2025: 2 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem15
  • High Capture Threshold8
  • High impedance5
  • Defective Device3
  • Failure to Capture3
  • Device Dislodged or Dislocated2
  • Difficult To Position1
  • Difficult to Remove1

Patient problems

  • Unspecified Infection16
  • No Code Available7
  • No Clinical Signs, Symptoms or Conditions5
  • Sepsis4
  • No Consequences Or Impact To Patient3
  • No Known Impact Or Consequence To Patient2
  • Atrial Fibrillation1
  • Erosion1

Recent adverse event reports

The 25 most recent of 30 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 21, 2025Device Dislodged or Dislocated; Device Dislodged or Dislocated

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD EXHIBITED DISLODGEMENT. THIS LV LEAD WAS SURGICALLY ABANDONED. A NEW LEAD WITH A DIFFERENT MODEL WAS SUCCESSFULLY IMPLANTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22869311 ↗
  • InjuryAug 7, 2025High Capture Threshold; High Capture Threshold

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD WAS SURGICALLY ABANDONED DUE TO HIGH PACING THRESHOLD. NO NEW LEAD WAS IMPLANTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22745375 ↗
  • InjuryJun 12, 2025Defective Device; Defective Device

    IT WAS REPORTED THAT PART OF THIS LEFT VENTRICULAR (LV) LEAD WAS BROKEN AND WAS STILL IN THE PATIENT CORONARY SINUS BRANCH. IN ADDITION, THE PATIENT WITH THIS LV LEAD EXPERIENCED INFECTION. THIS LV LEAD WAS SURGICALLY EXPLANTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Foreign Body In Patient; Unspecified Infection

    MAUDE report 22194067 ↗
  • InjuryMay 28, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD WAS PART OF THE SYSTEM REVISION DUE TO INFECTION. NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THE LV LEAD WAS EXPLANTED.

    Patient problems: Unspecified Infection

    MAUDE report 22093739 ↗
  • InjuryMay 8, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD WAS PART OF THE SYSTEM REVISION DUE TO POCKET EROSION AND INFECTION. REPORTEDLY, THE PATIENT LOST A LOT OF WEIGHT. NO ADVERSE PATIENT EFFECTS WERE REPORTED. THE LV LEAD WAS EXPLANTED.

    Patient problems: Pocket Erosion; Unspecified Infection

    MAUDE report 21990792 ↗
  • InjuryApr 20, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD WAS PART OF A SYSTEM REVISION DUE TO INFECTION. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THE LV LEAD WAS EXPLANTED.

    Patient problems: Unspecified Infection

    MAUDE report 21870260 ↗
  • InjuryDec 3, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD WAS PART OF A SYSTEM REVISION DUE TO VEGETATION ON LEADS. THIS LEAD WAS EXPLANTED. IN ADDITION, THE PHYSICIAN ALSO PERFORMED ANGIOVAC PROCEDURE. THERE WAS NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED.

    Patient problems: Unspecified Infection

    MAUDE report 20830694 ↗
  • InjuryJan 1, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD WAS PART OF A SYSTEM REVISION DUE TO INFECTION. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THIS LV LEAD WAS EXPLANTED.

    Patient problems: Unspecified Infection

    MAUDE report 18423191 ↗
  • InjuryJun 22, 2023High Capture Threshold; High Capture Threshold

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD EXHIBITED HIGH PACING THRESHOLDS. THE LEAD WAS SURGICALLY ABANDONED, AND A NEW LEAD WAS PLACED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17183018 ↗
  • InjuryJan 4, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD WAS PART OF A SYSTEM REVISION DUE TO POCKET INFECTION AND EROSION. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THE LV LEAD WAS EXPLANTED.

    Patient problems: Erosion; Unspecified Infection

    MAUDE report 16098727 ↗
  • InjuryMay 5, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THIS PACEMAKER LEAD WAS EXPLANTED DUE TO POCKET INFECTION. A NEW LEAD OF A DIFFERENT MODEL WAS SUCCESSFULLY IMPLANTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. RETURN OF THE LEAD IS NOT EXPECTED AS IT REMAINS WITH THE EXPLANTING FACILITY. IF THE LEAD IS RETURNED FOR ANALYSIS, THIS REPORT WILL BE UPDATED WITH PERTINENT INFORMATION UPON COMPLETION OF PRODUCT ANALYSIS.

    Patient problems: Unspecified Infection

    MAUDE report 14290801 ↗
  • InjuryMar 4, 2022High Capture Threshold; High Capture Threshold

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD WAS CAPPED AND SURGICALLY ABANDONED DUE HIGH PACING THRESHOLDS. OVER THE LAST SIX MONTHS. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 13675631 ↗
  • InjuryNov 6, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THE PATIENT WITH THIS LEFT VENTRICULAR (LV) LEAD WAS PART OF A SYSTEM REVISION DUE TO INFECTION WITH SEPSIS. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THE LV LEAD WAS EXPLANTED.

    Patient problems: Sepsis; Unspecified Infection

    MAUDE report 12755950 ↗
  • InjuryJul 8, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD WAS PART OF A SYSTEM REVISION DUE TO INFECTION WITH SEPSIS. REPORTEDLY, THE PATIENT ALSO HAD WOUND DEHISCENCE. THE PATIENT WAS TREATED WITH INTRAVENOUS ANTIBIOTICS. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THE LV LEAD WAS EXPLANTED.

    Patient problems: Sepsis; Unspecified Infection; Wound Dehiscence

    MAUDE report 12139240 ↗
  • InjuryApr 26, 2021High impedance; High Capture Threshold; High impedance; High Capture Threshold

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD EXHIBITED HIGH PACING THRESHOLD MEASUREMENTS AND HIGH OUT OF RANGE PACING IMPEDANCE MEASUREMENTS GREATER THAN 2,000 OHMS. SURGICAL INTERVENTION WAS UNDERTAKEN. THE LEAD WAS SURGICALLY ABANDONED AND REPLACED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11729854 ↗
  • InjuryJan 3, 2021High Capture Threshold; High Capture Threshold

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR LEAD WAS SURGICALLY ABANDONED DUE TO UNKNOWN PRODUCT PERFORMANCE ISSUE. ADDITIONAL INFORMATION FROM THE FIELD REPRESENTATIVE INDICATES THAT THIS LEAD EXHIBITED HIGH CAPTURE THRESHOLD DUE TO APPARENT PATIENT CONDITION. THIS LEAD WAS REPLACED FOR A NON-BOSTON SCIENTIFIC PRODUCT. NO ADDITIONAL ADVERSE PATIENT EFFECTS.

    Patient problems: No Code Available

    MAUDE report 11105347 ↗
  • InjuryNov 5, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THIS RIGHT VENTRICULAR (RV) LEAD WAS PART OF A SYSTEM REVISION DUE TO INFECTION WITH SEPSIS. THERE WERE NO ADVERSE PATIENT EFFECTS REPORTED. THIS RV LEAD WAS EXPLANTED.

    Patient problems: No Code Available; Sepsis; Unspecified Infection

    MAUDE report 10797096 ↗
  • InjuryNov 5, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD WAS PART OF A SYSTEM REVISION DUE TO INFECTION. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THE LV LEAD WAS CAPPED.

    Patient problems: No Code Available; Unspecified Infection

    MAUDE report 10796861 ↗
  • InjuryOct 2, 2020High impedance; Difficult to Remove; High Capture Threshold; High impedance; Difficult to Remove; High Capture Threshold

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD WAS SURGICALLY ABANDONED AS IT SHOWED HIGH, OUT OF RANGE IMPEDANCE WITH HIGH PACING THRESHOLDS. THE LEAD WAS ATTEMPTED TO BE REMOVED, BUT THE DISTAL END OF THE LV WOULDN'T BUDGE FROM THE CORONARY SINUS. THE RIGHT VENTRICULAR (RV) LEAD WAS EXPLANTED AND THE RIGHT ATRIAL (RA) LEAD WAS ABANDONED AT THE SAME PROCEDURE. NEW LEADS WERE IMPLANTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: No Code Available

    MAUDE report 10619668 ↗
  • InjuryJul 2, 2020Defective Device; Adverse Event Without Identified Device or Use Problem; Defective Device; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD WAS PART OF A SYSTEM REVISION DUE TO INFECTION WITH SEPSIS. THE PATIENT WAS TREATED WITH INTRAVENOUS ANTIBIOTICS. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THE LV LEAD WAS SURGICALLY ABANDONED.

    Patient problems: No Code Available; Sepsis; Unspecified Infection

    MAUDE report 10227535 ↗
  • MalfunctionJul 2, 2020High impedance; High impedance

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD EXHIBITED HIGH OUT OF RANGE PACE IMPEDANCE MEASUREMENTS GREATER THAN 2000 OHMS FOR APPROXIMATELY ONE (1) YEAR. THE PATIENT WAS NOTED TO RECEIVE LV PACING THERAPY MOST OF THE TIME. BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) PROVIDED THIS INFORMATION TO THE PHYSICIAN PER THEIR REQUEST VIA A CONSULT REVIEW. THE LEAD REMAINS IN-SERVICE. NO PATIENT SYMPTOMS OR ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 10226706 ↗
  • InjuryMay 4, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THIS PATIENT UNDERWENT AN EXTRACTION PROCEDURE TO REMOVE A CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) DEVICE AND THE ASSOCIATED LEADS, DUE TO AN INFECTION. DURING REMOVAL OF THE LEFT VENTRICULAR (LV) LEAD USING LASER TECHNOLOGY, THE CORONARY SINUS WAS BADLY TORN AND REQUIRED AN URGENT SURGICAL INTERVENTION. THE PATIENT SURVIVED BUT WAS PLACED ON EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO). THE EXPLANTED PRODUCTS WERE NOT INTENDED TO BE RETURNED.

    Patient problems: No Code Available; Unspecified Infection; Vascular Dissection

    MAUDE report 10021446 ↗
  • InjuryApr 3, 2020High Capture Threshold; High Capture Threshold

    IT WAS REPORTED THAT THIS LEAD WAS CAPPED DUE TO HIGH PACING THRESHOLD AND DUE TO THE AGE OF THE LEAD. LEAD WAS REPLACED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: No Code Available

    MAUDE report 9925163 ↗
  • InjuryApr 3, 2020High Capture Threshold; High Capture Threshold

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD EXHIBITED HIGH THRESHOLD. THE LV LEAD WAS EXPLANTED AND A NEW LEAD WAS PLACED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Atrial Fibrillation

    MAUDE report 9923946 ↗
  • InjuryJan 6, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD WAS PART OF A SYSTEM REVISION DUE TO INFECTION. THE PATIENT ALSO HAD VEGETATION ON THE LEADS. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THE LV LEAD WAS EXPLANTED.

    Patient problems: Unspecified Infection

    MAUDE report 9550059 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P010012. One submission often covers many models, so check the product and lot details in each record.

  • Z-1671-2022 · Jul 7, 2022 · Open, Classified
    The PRM is intended to be used as part of the ZOOM LATITUDE Programming System to communicate with Boston Scientific implantable pulse generators. The software in use controls all
  • Z-0081-2018 · Oct 4, 2017 · Terminated
    RESONATE X4 CRT-D, Model G447, Sterile.
  • Z-0080-2018 · Oct 4, 2017 · Terminated
    MOMENTUM X4 CRT-D, Model G138, Sterile.
  • Z-0079-2018 · Oct 4, 2017 · Terminated
    VIGILANT X4 CRT-D, Model G247, Sterile. Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) are indicated for patients with heart failure who receive stable optimal pharma
  • Z-1556-2010 · Mar 15, 2010 · Terminated
    Boston Scientific LIVIAN Cardiac Resynchronization Therapy Defibrillator (CRT-D), models H220, H225, H227, H229. The LIVIAN family of cardiac resynchronization therapy defibrillat
  • Z-0609-2010 · Dec 1, 2009 · Terminated
    Boston Scientific COGNIS CRT-D, Cardiac Resynchronization Therapy Defibrillator, models N118, N119. the following models are not available in the US: models N106, N107, P106, P107,
  • Z-1049-2007 · Mar 23, 2007 · Terminated
    CONTAK RENEWAL 3 RF (model H210, H215), CONTAK RENEWAL 3 RF HE (model H217, H219) cardiac resynchronization therapy defibrillator (CRT-D).
  • Z-1053-2007 · Mar 23, 2007 · Terminated
    VITALITY 2 (model T165, T175), VITALITY DS (model T125, T135), VITALITY EL (model T127), Implantable Cardioverter Defibrillators (ICD), are designed to detect and terminate ventric
  • Z-1054-2007 · Mar 23, 2007 · Terminated
    VITALITY DR HE Implantable Cardioverter Defibrillator (model T180). Sterile EO. Guidant Corporation, Cardiac Rhythm Management, 4100 Hamline Avenue North, St. Paul, MN 55112-5798 U
  • Z-1047-2007 · Mar 23, 2007 · Terminated
    CONTAK RENEWAL 3 (model H170, H175) CONTAK RENEWAL 3 HE (model H177, H179) Cardiac Resynchronization Therapy Defibrillator (CRT-D). Guidant Corporation, 4100 Hamline Avenue North,
  • Z-1052-2007 · Mar 23, 2007 · Terminated
    VITALITY AVT (model A155). Implantable Cardioverter Defibrillator. Atrial and Ventricular Therapies. Guidant Corporation Cardiac Rhythm Management, 4100 Hamline Avenue North, St. P
  • Z-1055-2007 · Mar 23, 2007 · Terminated
    VITALITY 2 EL DR/VR (model T167, T177). contents have been sterilized with gaseous ethylene oxide. The Guidant Vitality 2 ICD, implantable cardioverter defibrillators, are design
  • Z-0047-2008 · Mar 16, 2007 · Terminated
    Guidant VITALITY VR/DR, Implantable Cardioverter Defibrillator, ICD, Models 1870 and 1871. Guidant VITALITY DR+, Implantable Cardioverter Defibrillator, ICD, Model 1872.
  • Z-1288-06 · May 15, 2006 · Terminated
    Guidant CONTAK RENEWAL 3 (models H170, H175) CONTAK RENEWAL 3 HE (models H177, H179) Cardiac Resynchronization Therapy Defibrillator (CRT-D). Guidant Corporation, 4100 Hamline Ave
  • Z-0826-06 · Apr 7, 2006 · Terminated
    Guidant CONTAK RENEWAL 4 (models H190, H195) CONTAK RENEWAL; 4 HE (model H197). Cardiac Resynchronization Therapy Defibrillator (CRT-D). Sterile EO. Guidant Corporation, 4100 Ha

…and 4 more.

Other Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D) devices

All Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D) devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page